NCT02946892View on ClinicalTrials.gov

Effect of Carvedilol on Exercise Performance in Fontan Patients

PHASE4CompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

November 30, 2016

Primary Completion Date

December 31, 2019

Study Completion Date

January 31, 2020

Conditions
Single VentricleFontan
Interventions
DRUG

Carvedilol

Carvedilol will be given for 12 weeks and then an exercise test will be performed

DRUG

Placebo

Placebo will be given for 12 weeks and then an exercise test will be performed

Trial Locations (1)

75390

University of Texas Southwestern, Dallas

All Listed Sponsors
collaborator

American Heart Association

OTHER

lead

University of Texas Southwestern Medical Center

OTHER

NCT02946892 - Effect of Carvedilol on Exercise Performance in Fontan Patients | Biotech Hunter | Biotech Hunter